CDK4/6 inhibitor(palbocilcib) efficacy for head and neck squamous cell carcinoma(HNSCC), including both HPV plus and HPV- cell lines

被引:2
|
作者
Chen, Jo-Pai [1 ]
Chang, Jui-Ying [1 ]
Hong, Reuy-Long [2 ]
机构
[1] Natl Taiwan Univ Hosp, Yun Lin Branch, Yunlin, Taiwan
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
关键词
D O I
10.1158/1538-7445.AM2019-4408
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4408
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Exosomal miRNA as possible liquid biomarker for HPV plus Head and Neck Squamous Cell Carcinoma
    Oberste, Maximilian
    Apeltrath, Carla
    Riders, Armands
    Simon, Frank
    Rudack, Claudia
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 241 - 241
  • [42] A phase I trial of the addition of the CDK 4/6 inhibitor palbociclib to cetuximab in patients with incurable head and neck squamous cell carcinoma (HNSCC).
    Michel, Loren S.
    Ley, Jessica C.
    Wildes, Tanya Marya
    Trinkaus, Kathryn
    Adkins, Douglas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] Concurrent HPV Negative Squamous Cell Carcinoma of Anal Canal and Squamous Cell Carcinoma of Head and Neck
    Mehta, Vivek
    Khan, Uzma
    Pozzessere, Nicholas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S181 - S182
  • [44] Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC).
    Uppaluri, Ravindra
    Zolkind, Paul
    Lin, Tianxiang
    Nussenbaum, Brian
    Jackson, Ryan S.
    Rich, Jason
    Pipkorn, Patrik
    Paniello, Randal
    Thorstad, Wade
    Michel, Loren
    Mudianto, Tenny
    Oppelt, Peter John
    Wildes, Tanya Marya
    Dunn, Gavin P.
    Piccirillo, Jay F.
    Kallogjeri, Donna
    Rodig, Scott
    Hagemann, Ian S.
    Chernock, Rebecca
    Adkins, Douglas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Immune Landscape and Role of Immunotherapy in Treatment of HPV-Associated Head and Neck Squamous Cell Carcinoma (HNSCC)
    Hannah R. Turbeville
    Tiffany A. Toni
    Clint Allen
    Current Otorhinolaryngology Reports, 2022, 10 : 96 - 107
  • [46] DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC)
    Sannigrahi, M. K.
    Sharma, Rajni
    Singh, Varinder
    Panda, Naresh K.
    Rattan, Vidya
    Khullar, Madhu
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 448 (1-2) : 321 - 333
  • [47] Immune Landscape and Role of Immunotherapy in Treatment of HPV-Associated Head and Neck Squamous Cell Carcinoma (HNSCC)
    Turbeville, Hannah R.
    Toni, Tiffany A.
    Allen, Clint
    CURRENT OTORHINOLARYNGOLOGY REPORTS, 2022, 10 (01) : 96 - 107
  • [48] DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC)
    M. K. Sannigrahi
    Rajni Sharma
    Varinder Singh
    Naresh K. Panda
    Vidya Rattan
    Madhu Khullar
    Molecular and Cellular Biochemistry, 2018, 448 : 321 - 333
  • [49] Identification of target genes involved in metastatic progression and in HPV infection of head and neck squamous cell carcinoma (HNSCC)
    Millon, R.
    Rickman, D.
    de Reynies, A.
    Thomas, E.
    Muller, D.
    Bronner, G.
    Abecassis, J.
    Wasylyk, B.
    ORAL ONCOLOGY, 2007, : 85 - 85
  • [50] The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
    Zhou, Chumin
    Parsons, Jason L.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2020, 22